An Overview of Imidazole and Its Analogues As Potent Anticancer Agents

References

• Reichert JM , WengerJB. Development trends for new cancer therapeutics and vaccines. Drug Discov. Today13(1–2), 30–37 (2008).
   PubMed Web of Science ®Google Scholar
• Ali I , LoneMN , Aboul-EneinHY. Imidazoles as potential anticancer agents. MedChemComm8(9), 1742–1773 (2017).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD , JemalA. Cancer statistics, 2020. CA Cancer J. Clin.70(1), 7–30 (2020).
   PubMed Web of Science ®Google Scholar
• Ferlay J , ErvikM , LamFet al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon, France (2020). https://gco.iarc.fr/today
   Google Scholar
• Tsimberidou A-M . Targeted therapy in cancer. Cancer Chemother. Pharmacol.76(6), 1113–1132 (2015).
   PubMed Web of Science ®Google Scholar
• Seebacher NA , StacyAE , PorterGM , MerlotAM. Clinical development of targeted and immune based anti-cancer therapies. J. Exp. Clin. Cancer Res.38(1), 156 (2019).
   PubMedGoogle Scholar
• Rana A , AlexJ , ChauhanM , JoshiG , KumarR. A review on pharmacophoric designs of antiproliferative agents. Med. Chem. Res.24, 903–920 (2014).
   Web of Science ®Google Scholar
• Vitaku E , SmithDT , NjardarsonJT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective. J. Med. Chem.57(24), 10257–10274 (2014).
   PubMed Web of Science ®Google Scholar
• Vitaku E , SmithDT , NjardarsonJT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem.57(24), 10257–10274 (2014).
   PubMed Web of Science ®Google Scholar
• Li X-L , HuY-J , WangH , YuB-Q , YueH-L. Molecular spectroscopy evidence of berberine binding to DNA: comparative binding and thermodynamic profile of intercalation. Biomacromolecules13(3), 873–880 (2012).
   PubMed Web of Science ®Google Scholar
• Alniss HY , AnthonyNG , KhalafAIet al. Rationalising sequence selection by ligand assemblies in the DNA minor groove: the case for thiazotropsin A. Chem. Sci.3(3), 711–722 (2012).
   Web of Science ®Google Scholar
• Ketron AC , DennyWA , GravesDE , OsheroffN. Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions. Biochemistry51(8), 1730–1739 (2012).
   PubMed Web of Science ®Google Scholar
• Świderski G , ŁaźnyR , SienkiewiczMet al. Synthesis, spectroscopic, and theoretical study of copper and cobalt complexes with dacarbazine. Materials (Basel)14(12), 12 (2021).
   Web of Science ®Google Scholar
• Groessl M , ReisnerE , HartingerCGet al. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity. J. Med. Chem.50(9), 2185–2193 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang L , PengX , DamuGLV , GengR , ZhouC. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med. Res. Rev.34(2), 340–437 (2014).
   PubMed Web of Science ®Google Scholar
• Sharma P , LarosaC , AntwiJ , GovindarajanR , WerbovetzKA. Imidazoles as potential anticancer agents: an update on recent studies. Molecules26(14), 4213 (2021).
   PubMed Web of Science ®Google Scholar
• Molina P , TárragaA , OtónF. Imidazole derivatives: a comprehensive survey of their recognition properties. Org. Biomol. Chem.10(9), 1711–1724 (2012).
   PubMed Web of Science ®Google Scholar
• Kanawaade P , SharmaN , PandhareR , KanawadeMP. A review on: imidazole derivatives as a multifunctional moiety. Eur. J. Mol. Clin. Med.10(01), 4382–4405 (2023).
   Google Scholar
• Aleksandrova EV , KravchenkoAN , KocherginPM. Properties of haloimidazoles (review). Chem. Heterocycl. Compd47(3), 261 (2011).
   Web of Science ®Google Scholar
• Narasimhan B , SharmaD , KumarP. Biological importance of imidazole nucleus in the new millennium. Med. Chem. Res.20, 1119–1140 (2010).
   Web of Science ®Google Scholar
• Boiani M , GonzálezM. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini Rev. Med. Chem.5(4), 409–424 (2005).
   PubMed Web of Science ®Google Scholar
• Tolomeu HV , FragaCAM. Imidazole: synthesis, functionalization and physicochemical properties of a privileged structure in medicinal chemistry. Molecules28(2), 838 (2023).
   PubMed Web of Science ®Google Scholar
• Debus H . Ueber die einwirkung des ammoniaks auf glyoxal. Eur. J. Org. Chem.107(2), 199–208 (1858).
   Google Scholar
• Zheng X , MaZ , ZhangD. Synthesis of imidazole-based medicinal molecules utilizing the van leusen imidazole synthesis. Pharmaceuticals13(3), 37 (2020).
   Web of Science ®Google Scholar
• Akritopoulou-Zanze I . Isocyanide-based multicomponent reactions in drug discovery. Curr. Opin. Chem. Biol.12(3), 324–331 (2008).
   PubMed Web of Science ®Google Scholar
• Lujan-Montelongo JA , EstevezAO , FlemingFF. Alkyl sulfinates: formal nucleophiles for synthesizing TosMIC analogs. Eur. J. Org. Chem.2015(7), 1602–1605 (2015).
   PubMed Web of Science ®Google Scholar
• Mathiyazhagan AD , AnilkumarG. Recent advances and applications of p-toluenesulfonylmethyl isocyanide (TosMIC). Org. Biomol. Chem.17(28), 6735–6747 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang C , MoranEJ , WoiwodeTF , ShortKM , MjalliAMM. Synthesis of tetrasubstituted imidazoles via α-(N-acyl-N-alkylamino)-β-ketoamides on Wang resin. Tetrahedron Lett.37(6), 751–754 (1996).
   Web of Science ®Google Scholar
• Balalaie S , HashemiM , AkhbariM. A novel one-pot synthesis of tetrasubstituted imidazoles under solvent-free conditions and microwave irradiation. Tetrahedron Lett.44, 1709–1711 (2003).
   Web of Science ®Google Scholar
• Wolkenberg SE , WisnoskiDD , LeisterWH , WangY , ZhaoZ , LindsleyCW. Efficient synthesis of imidazoles from aldehydes and 1,2-diketones using microwave irradiation. Org. Lett.6(9), 1453–1456 (2004).
   PubMed Web of Science ®Google Scholar
• Vorbrüggen H , KrolikiewiczK. A simple synthesis of Δ2-oxazolines, Δ2-oxazines, Δ2-thiazolines and Δ2-imidazolines. Tetrahedron Lett.22(45), 4471–4474 (1981).
   Web of Science ®Google Scholar
• Pathan M , PaikeV , PachmaseP , MoreS , ArdhapureS , PawarR. Microwave-assisted facile synthesis of 2-substituted 2-imidazolines. Ark. Arch. Org. Chem.2006(15), 205–210 (2006).
   Google Scholar
• Sharma AK . A convenient approach for the synthesis of imidazole derivatives using microwaves. Der. Pharm. Lett.6(3), 431–447 (2012).
   Google Scholar
• Chakravarthi BVSK , PathiSS , GoswamiMTet al. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. Oncotarget5(16), 6654–6669 (2014).
   PubMedGoogle Scholar
• Cragg GM , GrothausPG , NewmanDJ. Impact of natural products on developing new anti-cancer agents. Chem. Rev.109(7), 3012–3043 (2009).
   PubMed Web of Science ®Google Scholar
• Peng X-M , DamuGLV , ZhouC. Current developments of coumarin compounds in medicinal chemistry. Curr. Pharm. Des.19, 3884–3930 (2013).
   PubMed Web of Science ®Google Scholar
• Montaseri H , KrugerCA , AbrahamseH. Recent advances in porphyrin-based inorganic nanoparticles for cancer treatment. Int. J. Mol. Sci.21(9), 3358 (2020).
   PubMed Web of Science ®Google Scholar
• Bae SH , ParkJH , ChoiHG , KimH , KimSH. Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells. Biomol. Ther. (Seoul)26(5), 494–502 (2018).
   PubMed Web of Science ®Google Scholar
• Parker AL , KavallarisM , McCarrollJA. Microtubules and their role in cellular stress in cancer. Front. Oncol.4, 153 (2014).
   PubMedGoogle Scholar
• Florian S , MitchisonTJ. Anti-microtubule drugs. Mitotic Spindl. Methods Protoc.1413, 403–421 (2016).
   Google Scholar
• Lu Y , ChenJ , XiaoM , LiW , MillerDD. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm. Res.29(11), 2943–2971 (2012).
   PubMed Web of Science ®Google Scholar
• Shan Y , ZhangJ , LiuZ , WangM , DongY. Developments of combretastatin A-4 derivatives as anticancer agents. Curr. Med. Chem.18(4), 523–538 (2011).
   PubMed Web of Science ®Google Scholar
• Chaudhary A , PandeyaSN , KumarPet al. Combretastatin a-4 analogs as anticancer agents. Mini Rev. Med. Chem.7(12), 1186–1205 (2007).
   PubMed Web of Science ®Google Scholar
• Lu Y , LiC-M , WangZet al. Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships. J. Med. Chem.52(6), 1701–1711 (2009).
   PubMed Web of Science ®Google Scholar
• Romagnoli R , BaraldiPG , Cruz-LopezOet al. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. J. Med. Chem.53(10), 4248–4258 (2010).
   PubMed Web of Science ®Google Scholar
• Beale TM , MyersRM , ShearmanJWet al. Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4. MedChemCommun1(3), 202–208 (2010).
   Web of Science ®Google Scholar
• Biersack B , MuthukumarY , SchobertR , SasseF. Cytotoxic and antivascular 1-methyl-4-(3-fluoro-4-methoxyphenyl)-5-(halophenyl)-imidazoles. Bioorg. Med. Chem. Lett.21(21), 6270–6273 (2011).
   PubMed Web of Science ®Google Scholar
• Rahimzadeh Oskuei S , MirzaeiS , RezaJafari-Nik Met al. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Bioorg. Chem.112, doi: 10.1016/j.bioorg.2021.104904 (2021).
   Web of Science ®Google Scholar
• Lindel T , JensenPR , FenicalWet al. Eleutherobin, a new cytotoxin that mimics paclitaxel (taxol) by stabilizing microtubules. J. Am. Chem. Soc.119(37), 8744–8745 (1997).
   Web of Science ®Google Scholar
• Long BH , CarboniJM , WassermanAJet al. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). Cancer Res.58(6), 1111–1115 (1998).
   PubMed Web of Science ®Google Scholar
• Hamel E , SackettDL , VourloumisD , NicolaouKC. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry38(17), 5490–5498 (1999).
   PubMed Web of Science ®Google Scholar
• Nicolaou KC , van DelftF , OhshimaTet al. Total synthesis of eleutherobin. Angew. Chemie Int. Ed. Engl.36(22), 2520–2524 (1997).
   Web of Science ®Google Scholar
• Nicolaou KC , KimS , PfefferkornJet al. Synthesis and biological activity of sarcodictyins. Angew. Chemie Int. Ed.37(10), 1418–1421 (1998).
   PubMed Web of Science ®Google Scholar
• LaBarbera DV , ModzelewskaK , GlazarAIet al. The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells. Anticancer Drugs20(6), 425–436 (2009).
   PubMed Web of Science ®Google Scholar
• Bielawski K , BielawskaA , PoplawskaB. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine. Arch. Pharm. (Weinheim)342(8), 484–490 (2009).
   PubMed Web of Science ®Google Scholar
• Li W-T , HwangD-R , SongJ-Set al. Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents. Invest. New Drugs30(1), 164–175 (2012).
   PubMed Web of Science ®Google Scholar
• Li L , QuanD , ChenJet al. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents. Eur. J. Med. Chem.184, doi:10.1016/j.ejmech.2019.111732 (2019) (Epub ahead of print).
   Web of Science ®Google Scholar
• Wang Q , ArnstKE , WangYet al. Structural modification of the 3,4,5-trimethoxyphenyl moiety in the tubulin inhibitor VERU-111 leads to improved antiproliferative activities. J. Med. Chem.61(17), 7877–7891 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Q , ArnstKE , WangYet al. Structure-guided design, synthesis, and biological evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) methanone (ABI-231) analogues targeting the colchicine binding site in tubulin. J. Med. Chem.62(14), 6734–6750 (2019).
   PubMed Web of Science ®Google Scholar
• Bai Z , LiuX , GuanQet al. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells. Chem. Biol. Interact.315, doi:10.1016/j.cbi.2019.108886 (2020) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Sayeed IB , VishnuvardhanMVPS , NagarajanA , KantevariS , KamalA. Imidazopyridine linked triazoles as tubulin inhibitors, effectively triggering apoptosis in lung cancer cell line. Bioorg. Chem.80, 714–720 (2018).
   PubMed Web of Science ®Google Scholar
• Mullagiri K , NayakVL , SunkariSet al. New (3-(1H-benzo[d]imidazol-2-yl))/(3-(3H-imidazo[4,5-b]pyridin-2-yl))-(1H-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates as tubulin polymerization inhibitors. MedChemComm9(2), 275–281 (2018).
   PubMed Web of Science ®Google Scholar
• Narasimha Rao MP , NagarajuB , KovvuriJet al. Synthesis of imidazo-thiadiazole linked indolinone conjugates and evaluated their microtubule network disrupting and apoptosis inducing ability. Bioorg. Chem.76, 420–436 (2018).
   PubMed Web of Science ®Google Scholar
• Baig MF , NayakVL , BudaganaboyinaPet al. Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents. Bioorg. Chem.77, 515–526 (2018).
   PubMed Web of Science ®Google Scholar
• Donthiboina K , AnchiP , GurramSet al. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Bioorg. Chem.103, doi:10.1016/j.bioorg.2020.104191 (2020) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Wang Y-T , ShiT-Q , ZhuH-L , LiuC-H. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Bioorg. Med. Chem.27(3), 502–515 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang Q , HuX , WanGet al. Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer. Eur. J. Med. Chem.184, doi:10.1016/j.ejmech.2019.111728 (2019) (Epub ahead of print).
   Web of Science ®Google Scholar
• Hu X , LiL , ZhangQet al. Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site. Bioorg. Chem.97, doi:10.1016/j.bioorg.2020.103695 (2020) (Epub ahead of print).
   Web of Science ®Google Scholar
• Wang L , ZhangJ , WanL , ZhouX , WangZ , WeiW. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol. Ther.151, 141–151 (2015).
   PubMed Web of Science ®Google Scholar
• Huang P , LeX , HuangFet al. Discovery of a dual tubulin polymerization and cell division cycle 20 homologue inhibitor via structural modification on apcin. J. Med. Chem.63(9), 4685–4700 (2020).
   PubMed Web of Science ®Google Scholar
• Coussens L , ParkerPJ , RheeLet al. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science233(4766), 859–866 (1986).
   PubMed Web of Science ®Google Scholar
• Manning G , WhyteDB , MartinezR , HunterT , SudarsanamS. The protein kinase complement of the human genome. Science298(5600), 1912–1934 (2002).
   PubMed Web of Science ®Google Scholar
• Bhullar KS , LagarónNO , McGowanEMet al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer17(1), 48 (2018).
   PubMedGoogle Scholar
• Bardelli A , ParsonsDW , SillimanNet al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science300(5621), 949 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrara N , AdamisAP. Ten years of anti-vascular endothelial growth factor therapy. Nat. Rev. Drug Discov.15(6), 385–403 (2016).
   PubMed Web of Science ®Google Scholar
• Gerber H-P , FerraraN. Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res.65(3), 671–680 (2005).
   PubMed Web of Science ®Google Scholar
• Albini A , TosettiF , LiVW , NoonanDM , LiWW. Cancer prevention by targeting angiogenesis. Nat. Rev. Clin. Oncol.9(9), 498–509 (2012).
   PubMed Web of Science ®Google Scholar
• Liekens S , DeClercq E , NeytsJ. Angiogenesis: regulators and clinical applications. Biochem. Pharmacol.61(3), 253–270 (2001).
   PubMed Web of Science ®Google Scholar
• Yadav L , PuriN , RastogiV , SatputeP , SharmaV. Tumour angiogenesis and angiogenic inhibitors: a review. J. Clin. Diagn. Res.9(6), XE01–XE05 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang QX , MagovernCJ , MackCA , BudenbenderKT , KoW , RosengartTK. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J. Surg. Res.67(2), 147–154 (1997).
   PubMed Web of Science ®Google Scholar
• Shibuya M . Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer2(12), 1097–1105 (2011).
   PubMedGoogle Scholar
• Olsson A-K , DimbergA , KreugerJ , Claesson-WelshL. VEGF receptor signalling–in control of vascular function. Nat. Rev. Mol. Cell Biol.7(5), 359–371 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson CJ , StringerSE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci.114(Pt 5), 853–865 (2001).
   PubMed Web of Science ®Google Scholar
• Sisko JT , TuckerTJ , BilodeauMTet al. Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase. Bioorg. Med. Chem. Lett.16(5), 1146–1150 (2006).
   PubMed Web of Science ®Google Scholar
• Wang C , GaoH , DongJet al. Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation. Bioorg. Med. Chem.22(1), 277–284 (2014).
   PubMed Web of Science ®Google Scholar
• Simons M , GordonE , Claesson-WelshL. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell Biol.17(10), 611–625 (2016).
   PubMed Web of Science ®Google Scholar
• Mostafa AS , GomaaRM , ElmorsyMA. Design and synthesis of 2-phenyl benzimidazole derivatives as VEGFR-2 inhibitors with anti-breast cancer activity. Chem. Biol. Drug Des.93(4), 454–463 (2019).
   PubMed Web of Science ®Google Scholar
• Huang SM , HarariPM. Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results. Invest. New Drugs17(3), 259–269 (1999).
   PubMed Web of Science ®Google Scholar
• Sigismund S , AvanzatoD , LanzettiL. Emerging functions of the EGFR in cancer. Mol. Oncol.12(1), 3–20 (2018).
   PubMed Web of Science ®Google Scholar
• Salomon DS , BrandtR , CiardielloF , NormannoN. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol.19(3), 183–232 (1995).
   PubMed Web of Science ®Google Scholar
• Schlessinger J . Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb. Perspect. Biol.6(3), a008912 (2014).
   PubMed Web of Science ®Google Scholar
• Yarden Y , PinesG. The ERBB network: at last, cancer therapy meets systems biology. Nat. Rev. Cancer12(8), 553–563 (2012).
   PubMed Web of Science ®Google Scholar
• Akhtar MJ , KhanAA , AliZet al. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Bioorg. Chem.78, 158–169 (2018).
   PubMed Web of Science ®Google Scholar
• Hickinson DM , KlinowskaT , SpeakeGet al. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer. Clin. Cancer Res.16(4), 1159–1169 (2010).
   PubMed Web of Science ®Google Scholar
• Amin KM , BarsoumFF , AwadallahFM , MohamedNE. Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity. Eur. J. Med. Chem.123, 191–201 (2016).
   PubMed Web of Science ®Google Scholar
• Hei Y-Y , ShenY , WangJet al. Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors. Bioorg. Med. Chem.26(8), 2173–2185 (2018).
   PubMed Web of Science ®Google Scholar
• Lei H , FanS , ZhangHet al. Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors. Eur. J. Med. Chem.186, doi:10.1016/j.ejmech.2019.111888 (2020) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Abou-Zied HA , YoussifBGM , MohamedMFA , HayallahAM , Abdel-AzizM. EGFR inhibitors and apoptotic inducers: design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules. Bioorg. Chem.89, doi:10.1016/j.bioorg.2019.102997 (2019).
   PubMed Web of Science ®Google Scholar
• Mitupatum T , AreeK , KittisenachaiSet al. mRNA expression of Bax, Bcl-2, p53, cathepsin B, caspase-3 and caspase-9 in the HepG2 cell line following induction by a novel monoclonal Ab Hep88 mAb: cross-talk for paraptosis and apoptosis. Asian Pac. J. Cancer Prev.17(2), 703–712 (2016).
   PubMedGoogle Scholar
• Hisham M , YoussifBGM , OsmanEEA , HayallahAM , Abdel-AzizM. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents. Eur. J. Med. Chem.176, 117–128 (2019).
   PubMed Web of Science ®Google Scholar
• Srour AM , AhmedNS , AbdEl-Karim SS , AnwarMM , El-HalloutySM. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors. Bioorg. Med. Chem.28(18), doi:10.1016/j.bmc.2020.115657 (2020).
   PubMed Web of Science ®Google Scholar
• Moerkens M , ZhangY , WesterL , vande Water B , MeermanJHN. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation. BMC Cancer14(1), 283 (2014).
   PubMedGoogle Scholar
• Nunes-Xavier CE , ElsonA , PulidoR. Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells. J. Biol. Chem.287(5), 3433–3444 (2012).
   PubMed Web of Science ®Google Scholar
• Amin KM , SyamYM , AnwarMM , AliHI , Abdel-GhaniTM , SerryAM. Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors. Bioorg. Chem.76, 487–500 (2018).
   PubMed Web of Science ®Google Scholar
• Hosamani KM , ReddyDS , DevarajegowdaHC. Microwave-assisted synthesis of new fluorinated coumarin–pyrimidine hybrids as potent anticancer agents{,} their DNA cleavage and x-ray crystal studies. RSC Adv.5(15), 11261–11271 (2015).
   Web of Science ®Google Scholar
• Luo G , TangZ , LaoK , LiX , YouQ , XiangH. Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERα/VEGFR-2 ligands with anti-breast cancer activity. Eur. J. Med. Chem.150, 783–795 (2018).
   PubMed Web of Science ®Google Scholar
• Nossier ES , El-halloutySM , ZakiER. Synthesis, anticancer evaluation and molecular modeling of some substituted thiazolidinonyl and thiazolyl pyrazole derivatives. Int. J. Pharm. Pharm. Sci.7(11), 353–359 (2015).
   Google Scholar
• Abbas H-AS , AbdEl-Karim SS. Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents. Bioorg. Chem.89, doi:10.1016/j.bioorg.2019.103035 (2019) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Syam YM , AnwarMM , KotbER , ElseginySA , AwadHM , AwadGEA. Development of promising thiopyrimidine-based anti-cancer and antimicrobial agents: synthesis and QSAR analysis. Mini Rev. Med. Chem.19(15), 1255–1275 (2019).
   PubMed Web of Science ®Google Scholar
• Kalra S , JoshiG , KumarMet al. Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition. RSC Med. Chem.11(8), 923–939 (2020).
   PubMedGoogle Scholar
• Sawant DM , SharmaS , PathareRSet al. Relay tricyclic Pd(ii)/Ag(i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR. Chem. Commun.54(82), 11530–11533 (2018).
   PubMed Web of Science ®Google Scholar
• Chauhan M , JoshiG , KlerHet al. Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold. RSC Adv.6(81), 77717–77734 (2016).
   Web of Science ®Google Scholar
• Joshi G , NayyarH , KalraSet al. Pyrimidine containing epidermal growth factor receptor kinase inhibitors: synthesis and biological evaluation. Chem. Biol. Drug Des.90(5), 995–1006 (2017).
   PubMed Web of Science ®Google Scholar
• Rous P . A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med.13(4), 397–411 (1911).
   PubMedGoogle Scholar
• Brown MT , CooperJA. Regulation, substrates and functions of src. Biochim. Biophys. Acta1287(2–3), 121–149 (1996).
   PubMed Web of Science ®Google Scholar
• Thomas SM , BruggeJS. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol.13, 513–609 (1997).
   PubMed Web of Science ®Google Scholar
• Jabbour E , KantarjianH. Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management. Am. J. Hematol.89(5), 547–556 (2014).
   PubMed Web of Science ®Google Scholar
• Wu P , NielsenTE , ClausenMH. FDA-approved small-molecule kinase inhibitors. Trends Pharmacol. Sci.36(7), 422–439 (2015).
   PubMed Web of Science ®Google Scholar
• Hassan AQ , SharmaSV , WarmuthM. Allosteric inhibition of BCR-ABL. Cell Cycle9(18), 3710–3714 (2010).
   PubMed Web of Science ®Google Scholar
• Roskoski RJ . Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol. Res.94, 9–25 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang J , YangPL , GrayNS. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer9(1), 28–39 (2009).
   PubMed Web of Science ®Google Scholar
• Francini CM , FallacaraAL , ArtusiRet al. Identification of aminoimidazole and aminothiazole derivatives as Src family kinase inhibitors. ChemMedChem10(12), 2027–2041 (2015).
   PubMed Web of Science ®Google Scholar
• Bertrand J , DostálováH , KrystofVet al. New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia. Bioorg. Chem.94, doi:10.1016/j.bioorg.2019.103361 (2020) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Liang C , TianD , RenXet al. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: a mini-review. Eur. J. Med. Chem.151, 315–326 (2018).
   PubMed Web of Science ®Google Scholar
• Desogus A , SchenoneS , BrulloC , TintoriC , MusumeciF. Bcr-Abl tyrosine kinase inhibitors: a patent review. Expert Opin. Ther. Pat.25(4), 397–412 (2015).
   PubMed Web of Science ®Google Scholar
• Calderón-Arancibia J , Espinosa-BustosC , Cañete-MolinaÁet al. Synthesis and pharmacophore modelling of 2,6,9-trisubstituted purine derivatives and their potential role as apoptosis-inducing agents in cancer cell lines. Molecules20(4), 6808–6826 (2015).
   PubMed Web of Science ®Google Scholar
• Gucký T , ŘezníčkováE , RadošováMuchová Tet al. Discovery of N(2)-(4-Amino-cyclohexyl)-9-cyclopentyl- N(6)-(4-morpholin-4-ylmethyl-phenyl)- 9H-purine-2,6-diamine as a potent FLT3 kinase inhibitor for acute myeloid leukemia with FLT3 mutations. J. Med. Chem.61(9), 3855–3869 (2018).
   PubMed Web of Science ®Google Scholar
• Lorz PM , TowaeFK , EnkeW , JäckhR , BhargavaN , HillesheimW. Phthalic acid and derivatives. Ullmann's Encycl. Ind. Chem. doi:10.1002/14356007.a20_181 (2000).
   Google Scholar
• Storrie B , MaddenEA. Buffer for assay of horseradish peroxidase meth. Enzymologia182, 217 (1990).
   Google Scholar
• Nishie K , WaissACJr , KeylAC. Toxicity of methylimidazoles. Toxicol. Appl. Pharmacol.14(2), 301–307 (1969).
   PubMed Web of Science ®Google Scholar
• Shalini K , SharmaPK , KumarN. Imidazole and its biological activities: a review. Der Chem. Sin.1(3), 36–47 (2010).
   Google Scholar
• Chan PC , HillGD , KisslingGE , NyskaA. Toxicity and carcinogenicity studies of 4-methylimidazole in F344/N rats and B6C3F1 mice. Arch. Toxicol.82(1), 45–53 (2008).
   PubMed Web of Science ®Google Scholar
• Uçucu Ü , KaraburunNG , Işikdağİ. Synthesis and analgesic activity of some 1-benzyl-2-substituted-4, 5-diphenyl-1H-imidazole derivatives. Farmaco Sci.56(4), 285–290 (2001).
   PubMedGoogle Scholar
• Al-Azzawi RW . Evaluation of some properties of three types of denture reline materials with miconazole (antifungal agent) preparation. Master's Thesis, Prosthet. Dep. Univ. Baghdad (2007) ( Online).
   Google Scholar
• Ebeol K , KoehlerH , GamerAO , JackhR. Imidazole and derivatives. Ullmann's Encycl. Ind. Chem. Wiley18, 637–645 (2000).
   Google Scholar
• Chen H-L , KaoH-F , WangJ-Y , WeiG-T. Cytotoxicity of imidazole ionic liquids in human lung carcinoma A549 cell line. J. Chinese Chem. Soc.61(7), 763–769 (2014).
   Web of Science ®Google Scholar
• Nørregaard A , JensenSS , KolendaJet al. Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers. Neurotox. Res.22(1), 43–58 (2012).
   PubMed Web of Science ®Google Scholar
• Singh K , VermaV , YadavKet al. Design, regioselective synthesis and cytotoxic evaluation of 2-aminoimidazole-quinoline hybrids against cancer and primary endothelial cells. Eur. J. Med. Chem.87, 150–158 (2014).
   PubMed Web of Science ®Google Scholar
• Nepali K , LeeH-Y , LiouJ-P. Nitro-group-containing drugs. J. Med. Chem.62(6), 2851–2893 (2018).
   PubMed Web of Science ®Google Scholar
• Patterson S , WyllieS , NorvalSet al. The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis. Elife5, e09744 (2016).
   PubMed Web of Science ®Google Scholar
• Landge S , RamachandranV , KumarAet al. Nitroarenes as antitubercular agents: stereoelectronic modulation to mitigate mutagenicity. ChemMedChem11(3), 331–339 (2016).
   PubMed Web of Science ®Google Scholar
• Boechat N , CarvalhoAS , SalomãoKet al. Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group. Mem. Inst. Oswaldo Cruz110, 492–499 (2015).
   PubMed Web of Science ®Google Scholar
• Rojo G , CastilloC , DuasoJet al. Toxic and therapeutic effects of nifurtimox and benznidazol on Trypanosoma cruzi ex vivo infection of human placental chorionic villi explants. Acta Trop.132, 112–118 (2014).
   PubMed Web of Science ®Google Scholar
• Wilkinson SR , BotC , KellyJM , HallBS. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives. Curr. Top. Med. Chem.11(16), 2072–2084 (2011).
   PubMed Web of Science ®Google Scholar
• Alirol E , SchrumpfD , AmiciHeradi Jet al. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo. Clin. Infect. Dis.56(2), 195–203 (2013).
   PubMed Web of Science ®Google Scholar
• Davies C , DeyN , NegretteOS , ParadaLA , BasombrioMA , GargNJ. Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with benznidazole. PLOS Negl. Trop. Dis.8(10), e3231 (2014).
   PubMed Web of Science ®Google Scholar
• Minsky BD , LeibelSA. The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole. Cancer treatment reviews16(4), 213–9 (1989).
   PubMed Web of Science ®Google Scholar
• Bahia MT , AndradeIM , MartinsTAet al. Fexinidazole: a potential new drug candidate for Chagas disease. PLOS neglected tropical diseases6(11), e1870 (2012).
   PubMed Web of Science ®Google Scholar
• Bleehen NM , MaughanTS , WorkmanP , NewmanHF , StenningS , WardR. The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study. Radiother. Oncol.20, 137–142 (1991).
   PubMed Web of Science ®Google Scholar
• Carvalho AS , SalomãoK , CastroSLet al. Megazol and its bioisostere 4H-1, 2, 4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme. Mem. Inst. Oswaldo Cruz109, 315–323 (2014).
   PubMed Web of Science ®Google Scholar
• Matsumoto M , HashizumeH , TomishigeTet al. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLOS Med.3(11), e466 (2006).
   PubMed Web of Science ®Google Scholar